Two novel cases of trilateral retinoblastoma: genetics and review of the literature.

Gemma D'Elia, Simona Grotta, Francesca Del Bufalo, Maria Antonietta De Ioris, Cecilia Surace, Pietro Sirleto, Antonino Romanzo, Raffaele Cozza, Franco Locatelli, Adriano Angioni

Journal: Cancer genetics 2014;206(11):398-401

PMID: 24412019

Abstract

Retinoblastoma (RB) is the most common eye tumor in children; it originates from germline and/or somatic mutations that inactivate both alleles of the RB1 gene located on chromosome 13q14. Patients with unilateral or bilateral RB infrequently may develop an additional intracranial neuroblastic tumor, usually in the pineal gland, which characterizes the trilateral retinoblastoma (TRB) syndrome. The most common chromosomal abnormalities detected in TRB are deletions at 13q14, even if some rare cases of RB1 point mutations were described. In our report, we investigated two patients with TRB who showed a germline RB1 point mutation that has never been found to date and a large deletion involving RB1, respectively. Genetic data were compared to our in-house series and to current literature; these data suggested a role for other candidate regions in the pathogenesis of TRB. Moreover, our study highlights the need for new approaches allowing a multigenic analysis to clarify the genotype-phenotype correlation in TRB.

Copyright © 2013 Elsevier Inc. All rights reserved.

Address: Cytogenetics and Molecular Genetics Unit, Bambino Gesù Children's Hospital, Rome, Italy.; Cytogenetics and Molecular Genetics Unit, Bambino Gesù Children's Hospital, Rome, Italy. Electronic address: [email protected].; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Bambino Gesù Children's Hospital, Rome, Italy.; Ophthalmology Unit, Bambino Gesù Children's Hospital, Rome, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.